Patriot National Enters Into Serious Discussions With Ebix,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Patriot National Enters Into Serious Discussions With Ebix, Inc.

JOHNS CREEK, GA--(Marketwired - Aug 1, 2016) - Ebix, Inc. ( NASDAQ : EBIX ), a leading international supplier of on-demand software and e-commerce services to the insurance, financial, e-governance and healthcare industries, announced today the Special Committee of the Board of Directors of Patriot National ( NYSE : PN ) has agreed to consider an offer for a potential transaction with Ebix.

The Special Committee of the Board of Directors of Patriot National decided to enter into serious discussions with Ebix, while allowing Ebix to begin comprehensive due diligence into the Company, after Ebix sent a revised and improved offer to the Patriot National Special Committee. The improved Ebix offer of $475 million is expected to yield a price per share that significantly exceeds the company's initial offer, with Patriot paying all of its outstanding debt obligations, its related transaction expenses, and leaving a specified minimum amount of cash and receivables in the business.

"We are excited about the possibilities of this prospective merger. It would create the world's largest insurance services provider of straight through processing with a wide repertoire of end-to-end services under one roof, while complementing the relative strengths of both parties in terms of products, services and client base," said Robin Raina, Ebix Chairman of the Board, president and chief executive officer. "We see substantial synergies, economies of scale and expanded growth potential for the combined business. We believe that our offshore and technology capabilities would serve to further improve Patriot National's operating income substantially, making it a highly accretive transaction for both sides in the short term."

About Patriot National Patriot National, Inc. is a national provider of comprehensive technology and outsourcing solutions that help insurance companies and employers mitigate risk, comply with complex regulations and save time and money. Patriot National provides general agency services, technology outsourcing, software solutions, specialty underwriting and policyholder services, claims administration services, self-funded health plans and employment pre-screening services to its insurance carrier clients, employers and other clients. Patriot National is headquartered in Fort Lauderdale, Florida. For more information about Patriot National, please visit www.patnat.com

About Ebix A leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, Ebix, Inc. provides end-to-end on-Demand solutions ranging from infrastructure exchanges, front end & back end enterprise systems, outsourced administrative & custom software development solutions, and risk compliance solutions for various entities involved in these industries.

With 40+ offices across Australia, Brazil, Canada, India, New Zealand, Singapore, the US and the UK, Ebix powers multiple exchanges across the world in the field of life, annuity, health and property & casualty insurance while conducting in excess of $100 billion in insurance premiums annually on its platforms. Through its various SaaS-based software platforms, Ebix employs hundreds of domain specific business and technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company's website at www.ebix.com

SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS As used herein, the terms "Ebix," "the Company," "we," "our" and "us" refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

The information contained in this Press Release contains forward-looking statements and information within the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company's products by the market, and management's plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission ("SEC"), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "seeks," "plan," "project," "continue," "predict," "will," "should," and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company's ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.

Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto. You may obtain our SEC filings at our website, www.ebix.com under the "Investor Information" section, or over the Internet at the SEC's web site, www.sec.gov .

CONTACT: Darren Joseph Ebix, Inc. 678-281-2020 Email Contact David Collins or Chris Eddy Catalyst Global 212-924-9800 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 231

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 445

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 155

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 212

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Growth Stocks to Consider: Nvidia, Super Micro, Royal Caribbean

Updated Category News Views 255

Exploring High-Performing Stocks After the Pandemic Following the pandemic, the stock market has experienced a remarkable recovery, largely driven by advancements in artificial intelligence and a resurgence in travel demand. Among the standout performers in this landscape, three companies have particularly excelled, showcasing impressive growth potential. Let’s delve...

Continue Reading
Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 58

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
Nebius Group: A Thriving Alternative in AI Computing Sector

Updated Category News Views 453

Nebius Group N.V. Takes on Major Hyperscalers Analyst Alexander Platt from D.A. Davidson & Co. recently launched coverage on Nebius Group N.V. (NASDAQ: NBIS) with a Buy rating, showcasing a promising future as an alternative to leading hyperscalers in the AI computing space. Transforming AI Computing with Transparent Solutions The ever-evolving demand for AI solutions has...

Continue Reading
Innovative Waste Tracking Enhances Hospital Sustainability Efforts

Updated Category News Views 123

Enhancing Hospital Sustainability Through Waste Management In today's driven healthcare landscape, managing waste effectively is more important than ever. remedi, a notable player in the regulated medical waste processing sector, has recently announced an expansion of its waste tracking and reporting capabilities. This initiative aims to assist hospitals in gaining...

Continue Reading
Insights on Core Molding Technologies Stock Movements

Updated Category News Views 148

Core Molding Technologies Stock Activity Overview Recently, there’s been significant trading activity surrounding Core Molding Technologies Inc (NYSEMKT:CMT). Renee R. Anderson, the Executive Vice President of Human Resources, sold shares valued at $32,094. This sale involved 1,783 shares, each priced at $18.00, which caught the attention of both investors and market...

Continue Reading